Publications by authors named "Maryou B Lambros"

70Publications

Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate Cancer.

J Clin Oncol 2019 08 2;37(24):2182-2184. Epub 2019 Jul 2.

Adam Sharp, MD, PhD, The Institute of Cancer Research; The Royal Marsden, London, United Kingdom; Nuria Porta, PhD; Maryou B.K. Lambros, MPhil; and Jonathan C. Welti, PhD, The Institute of Cancer Research, London, United Kingdom; Alec Paschalis, MD, The Institute of Cancer Research; The Royal Marsden, London, United Kingdom; Ganesh V. Raj, MD, PhD, The University of Texas Southwestern Medical Center, Dallas, TX; Stephen P. Plymate, MD, University of Washington; VA Puget Sound Health Care System Geriatric Research Education and Clinical Center, Seattle, WA; and Johann S. de Bono, MD, PhD, The Institute of Cancer Research; The Royal Marsden, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01104DOI Listing
August 2019

Genomic profiling of histological special types of breast cancer.

Breast Cancer Res Treat 2013 Nov 27;142(2):257-69. Epub 2013 Oct 27.

Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2740-6DOI Listing
November 2013

PI3K pathway dependencies in endometrioid endometrial cancer cell lines.

Clin Cancer Res 2013 Jul 14;19(13):3533-44. Epub 2013 May 14.

Signal Transduction Laboratory, Cancer Research UK, London Research Institute, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700760PMC
July 2013

Non-existence of caveolin-1 gene mutations in human breast cancer.

Breast Cancer Res Treat 2012 Jan 11;131(1):307-10. Epub 2011 Sep 11.

The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1761-2DOI Listing
January 2012

High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform.

Lab Invest 2011 Oct 1;91(10):1491-501. Epub 2011 Aug 1.

Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/labinvest.2011.110DOI Listing
October 2011

Functional characterization of EMSY gene amplification in human cancers.

J Pathol 2011 Sep 7;225(1):29-42. Epub 2011 Jul 7.

Molecular Pathology Team, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2944DOI Listing
September 2011

Direct evidence for concurrent morphological and genetic heterogeneity in an invasive ductal carcinoma of triple-negative phenotype.

J Clin Pathol 2011 Sep 14;64(9):822-8. Epub 2011 Jun 14.

The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2011-200135DOI Listing
September 2011

Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas.

Clin Cancer Res 2011 Mar;17(6):1521-34

Department of Gynaecologic Oncology, Royal Marsden Hospital NHS Foundation Trust, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1688DOI Listing
March 2011

Absence of microsatellite instability in mucinous carcinomas of the breast.

Int J Clin Exp Pathol 2010 Nov 27;4(1):22-31. Epub 2010 Nov 27.

Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016101PMC
November 2010

β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.

Mod Pathol 2011 Feb 12;24(2):209-31. Epub 2010 Nov 12.

Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.205DOI Listing
February 2011

Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast.

Am J Surg Pathol 2010 Oct;34(10):1472-9

Department of Histopathology, Nottingham University Hospitals NHS Trust, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3181f01916DOI Listing
October 2010

Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer.

Eur J Cancer 2011 Jan 9;47(1):138-50. Epub 2010 Sep 9.

Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980491000788
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2010.08.007DOI Listing
January 2011

β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.

Mod Pathol 2010 Nov 6;23(11):1438-48. Epub 2010 Aug 6.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/modpathol2010141
Publisher Site
http://dx.doi.org/10.1038/modpathol.2010.141DOI Listing
November 2010

Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast.

Mod Pathol 2010 Jul 7;23(7):951-60. Epub 2010 May 7.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/modpathol201082
Publisher Site
http://dx.doi.org/10.1038/modpathol.2010.82DOI Listing
July 2010

Genetic characterization of breast cancer and implications for clinical management.

J Cell Mol Med 2009 Oct 14;13(10):4090-103. Epub 2009 Sep 14.

Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1582-4934.2009.00906.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496116PMC
October 2009

Molecular alterations of KIT oncogene in gliomas.

Cell Oncol 2007 ;29(5):399-408

Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618227PMC
http://dx.doi.org/10.1155/2007/926274DOI Listing
April 2008

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.

Breast Cancer Res Treat 2008 May 26;109(2):325-35. Epub 2007 Jul 26.

Department of Histopathology, School of Molecular Medical Sciences, Nottingham City Hospital NHS Trust, University of Nottingham and University Hospitals NHS Trust, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9659-8DOI Listing
May 2008

Chromogenic and fluorescent in situ hybridization in breast cancer.

Hum Pathol 2007 Aug;38(8):1105-22

Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, SW3 6JB London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2007.04.011DOI Listing
August 2007

Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research.

Lab Invest 2007 Aug 11;87(8):737-54. Epub 2007 Jun 11.

Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/labinvest.3700593DOI Listing
August 2007

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.

Breast Cancer Res 2007 ;9(2):R23

Department of Histopathology, School of Molecular Medical Sciences, Queen's Medical Centre, Nottingham University Hospitals Trust and University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868920PMC
June 2007

Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer.

Breast Cancer Res Treat 2007 Dec 27;106(2):181-9. Epub 2007 Jan 27.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Fulham Road, London SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-006-9492-5DOI Listing
December 2007

MYC amplification in breast cancer: a chromogenic in situ hybridisation study.

J Clin Pathol 2007 Sep 8;60(9):1017-23. Epub 2006 Dec 8.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jcp.2006.043869DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972423PMC
September 2007

Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.

Mod Pathol 2006 Jul 28;19(7):999-1009. Epub 2006 Apr 28.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.3800621DOI Listing
July 2006

Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization.

J Pathol 2005 Jan;205(1):29-40

Molecular and Population Genetics Laboratory, Cancer Research UK, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1681DOI Listing
January 2005

Loss of heterozygosity analysis: practically and conceptually flawed?

Genes Chromosomes Cancer 2002 Aug;34(4):349-53

Molecular and Population Genetics Laboratory, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.10085DOI Listing
August 2002